You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH):捷門生物獲3個醫療器械註冊證
格隆匯 03-16 17:35

格隆匯3月16日丨海利生物(603718.SH)公佈,公司全資子公司上海捷門生物技術有限公司(以下簡稱“捷門生物”)相關產品於近日收到上海市藥品監督管理局頒發的《醫療器械註冊證》(體外診斷試劑)。

抗鏈球菌溶血素“O”測定試劑盒(熒光免疫層析法)與捷門生物的乾式時間分辨熒光分析儀配套使用,供醫療機構用於體外測定人血清樣本中抗鏈球菌溶血素“O”的含量,作輔助診斷用。

類風濕因子測定試劑盒(熒光免疫層析法)與捷門生物的乾式時間分辨熒光分析儀配套使用,供醫療機構用於體外測定人血清樣本中類風濕因子的含量,作輔助診斷用。

C-反應蛋白測定試劑盒(熒光免疫層析法)與捷門生物的乾式時間分辨熒光分析儀配套使用,供醫療機構用於體外測定人血清、血漿、全血樣本中C-反應蛋白的含量,作輔助診斷用。

上述產品取得註冊證後,無須再履行其他審批程序即可上市銷售。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account